IP Library Granted Patent US 12,623,022
Granted Patent B1
US 12,623,022 · App. 19/064,323 · Granted May 12, 2026

Medicament delivery device

Inventors: Alexander Hee-Hanson (Melbourn, GB); Thomas Lever (Melbourn, GB); Michael Parrott (Melbourn, GB); Robert Wilson (Melbourn, GB); Haiming Wu (Cambridge, MA)
Assignee: Genzyme Corporation
A61M5/2033A61M2005/206A61M2005/2073A61M2005/2086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,623,022
App. No.
19/064,323
Granted
May 12, 2026
Kind
B1
Abstract

A medicament delivery device for injecting medicament is described. The device has a body having a proximal end and a distal end, a needle for injecting medicament, an actuation member which is movable relative to the body from a first position to a second position for dispensing medicament from the needle, a lock ring which is rotatable relative to the body from a pre-use position, in which movement of the actuation member from the first position to the second position is prevented, to a use position in which movement of the actuation member from the first position to the second position is permitted and a cap which is removably attached to the medicament delivery device. The cap has a portion which is configured to prevent rotation of the lock ring from the pre-use position to the use position when the cap is attached to the medicament delivery device.

Claims (46)

1 . A medicament delivery device for injecting medicament, wherein the medicament delivery device comprises:

a body having a proximal end and a distal end defining a longitudinal axis;

a needle;

an actuation member movable relative to the body from a first position to a second position for dispensing the medicament via the needle;

a lock ring rotatable relative to the body from a pre-use position in which movement of the actuation member from the first position to the second position is prevented, to a use position in which a movement of the actuation member from the first position to the second position is permitted;

an axially-extending component rotationally constrained relative to the lock ring,

wherein one of the axially-extending component and the lock ring comprises a first protrusion and the other of the axially-extending component and the lock ring comprises a first recess, and wherein the first protrusion is configured to be received in the first recess to constrain rotation of the axially-extending component relative to the lock ring, the axially-extending component being independently rotatable relative to the lock ring prior to engagement of the first protrusion and the first recess; and

a cap removably attached to the medicament delivery device, wherein the cap comprises a proximally-extending portion configured to engage the axially-extending component to prevent rotation of the lock ring from the pre-use position to the use position when the cap is attached to the medicament delivery device,

wherein one of the axially-extending component and the proximally-extending portion comprises a second protrusion and the other of the axially-extending component and the proximally-extending portion comprises a second recess, and wherein the second recess is a radially-extending recess extending towards the longitudinal axis and the second protrusion is a radially-extending protrusion extending towards the longitudinal axis and configured to be received in the radially-extending recess to rotationally constrain the proximally-extending portion relative to the axially-extending component when the cap is attached to the medicament delivery device, and wherein the engagement between the second protrusion and the second recess is released upon removal of the cap.

2 . The medicament delivery device according to claim 1 , wherein the cap is removably attached to the body.

3 . The medicament delivery device according to claim 1 , wherein the proximally-extending portion of the cap is rotationally constrained relative to the body when the cap is attached to the medicament delivery device.

4 . The medicament delivery device according to claim 3 , wherein one of the proximally-extending portion of the cap and the body comprises a third protrusion and the other of the proximally-extending portion of the cap and the body comprises a third recess, and

wherein the cap and the body are configured such that when the cap is attached to the medicament delivery device, the third protrusion is received in the third recess to constrain rotation of the portion of the cap relative to the body.

5 . The medicament delivery device according to claim 1 , wherein the proximally-extending portion of the cap engages the axially-extending component when the lock ring is in the pre-use position.

6 . The medicament delivery device according to claim 1 , wherein the axially-extending component and the proximally-extending portion of the cap are located radially inwards from the body.

7 . The medicament delivery device according to claim 1 , wherein the axially-extending component and the lock ring are separate components.

8 . The medicament delivery device according to claim 1 , wherein the proximally-extending portion of the cap is configured to prevent rotation of the lock ring relative to the body when the cap is attached to the medicament delivery device.

9 . The medicament delivery device according to claim 1 , wherein the actuation member is configured to be rotated with the lock ring when the lock ring rotates from the pre-use position to the use position.

10 . The medicament delivery device according to claim 1 , wherein the actuation member comprises a button configured to be pressed to move the actuation member from the first position to the second position.

11 . The medicament delivery device according to claim 1 , wherein the medicament delivery device comprises a dispensing mechanism configured to dispense medicament via the needle, and wherein the actuation member is configured to release the dispensing mechanism when the actuation member is in the second position.

12 . The medicament delivery device according to claim 1 , further comprising a container containing the medicament.

13 . The medicament delivery device of claim 1 , wherein the axially-extending component is a cylindrical sleeve.

14 . A method of preparing a medicament delivery device for use prior to dispensing medicament from the medicament delivery device, the method comprising:

removing a cap from the medicament delivery device, wherein the cap comprises a proximally-extending portion configured to prevent rotation of a lock ring of the medicament delivery device from a pre-use position to a use position; and

rotating the lock ring from the pre-use position to the use position,

wherein the medicament delivery device comprises:

a body having a proximal end and a distal end defining a longitudinal axis;

a needle;

an actuation member movable relative to the body from a first position to a second position for dispensing the medicament via the needle;

the lock ring rotatable relative to the body from the pre-use position in which movement of the actuation member from the first position to the second position is prevented, to the use position in which a movement of the actuation member from the first position to the second position is permitted;

an axially-extending component rotationally constrained relative to the lock ring,

wherein one of the axially-extending component and the lock ring comprises a first protrusion and the other of the axially-extending component and the lock ring comprises a first recess, and wherein the first protrusion is configured to be received in the first recess to constrain rotation of the axially-extending component relative to the lock ring, the axially-extending component being independently rotatable relative to the lock ring prior to engagement of the first protrusion and the first recess; and

the cap removably attached to the medicament delivery device, wherein the cap comprises a proximally-extending portion configured to engage the axially-extending component to prevent rotation of the lock ring from the pre-use position to the use position when the cap is attached to the medicament delivery device,

wherein one of the axially-extending component and the proximally-extending portion comprises a second protrusion and the other of the axially-extending component and the proximally-extending portion comprises a second recess, and wherein the second recess is a radially-extending recess extending towards the longitudinal axis and the second protrusion is a radially-extending protrusion extending towards the longitudinal axis and configured to be received in the radially-extending recess to rotationally constrain the proximally-extending portion relative to the axially-extending component when the cap is attached to the medicament delivery device, and wherein the engagement between the second protrusion and the second recess is released upon removal of the cap.

15 . A method of using a medicament delivery device, the method comprising:

removing a cap from the medicament delivery device, wherein the cap comprises a portion configured to prevent rotation of a lock ring of the medicament delivery device from a pre-use position to a use position;

rotating the lock ring from the pre-use position to the use position; and

moving an actuation member from a first position to a second position for dispensing medicament from the medicament delivery device, wherein the medicament delivery device comprises:

a body having a proximal end and a distal end defining a longitudinal axis;

a needle;

an actuation member movable relative to the body from a first position to a second position for dispensing the medicament via the needle;

the lock ring rotatable relative to the body from the pre-use position in which movement of the actuation member from the first position to the second position is prevented, to the use position in which a movement of the actuation member from the first position to the second position is permitted;

an axially-extending component rotationally constrained relative to the lock ring,

wherein one of the axially-extending component and the lock ring comprises a first protrusion and the other of the axially-extending component and the lock ring comprises a first recess, and wherein the first protrusion is configured to be received in the first recess to constrain rotation of the axially-extending component relative to the lock ring, the axially-extending component being independently rotatable relative to the lock ring prior to engagement of the first protrusion and the first recess; and

the cap removably attached to the medicament delivery device, wherein the cap comprises a proximally-extending portion configured to engage the axially-extending component to prevent rotation of the lock ring from the pre-use position to the use position when the cap is attached to the medicament delivery device,

wherein one of the axially-extending component and the proximally-extending portion comprises a second protrusion and the other of the axially-extending component and the proximally-extending portion comprises a second recess, and wherein the second recess is a radially-extending recess extending towards the longitudinal axis and the second protrusion is a radially-extending protrusion extending towards the longitudinal axis and configured to be received in the radially-extending recess to rotationally constrain the proximally-extending portion relative to the axially-extending component when the cap is attached to the medicament delivery device, and wherein the engagement between the second protrusion and the second recess is released upon removal of the cap.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2025
From: PA HOLDING LIMITED
To: PA CONSULTING SERVICES LIMITED
Reel/Frame 072504/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2025
From: HEE-HANSON, ALEXANDER; PARROTT, MICHAEL; LEVER, THOMAS; WILSON, ROBERT
To: PA HOLDINGS LIMITED
Reel/Frame 072139/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2025
From: PA CONSULTING SERVICES
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 072139/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2025
From: WU, HAIMING
To: GENZYME CORPORATION
Reel/Frame 072139/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2025
From: SANOFI-AVENTIS DEUTSCHLAND GMBH
To: GENZYME CORPORATION
Reel/Frame 072139/0648 →
References Cited (126)
US 2522961A · William · 1950 [cited by applicant]
US 2633267A · Lebus · 1953 [cited by applicant]
US 3886513A · Smith et al. · 1975 [cited by applicant]
US 3993063A · Larrabee · 1976 [cited by applicant]
US 4801295A · Spencer · 1989 [cited by applicant]
US 5045062A · Henson · 1991 [cited by applicant]
US 5176275A · Bowie · 1993 [cited by applicant]
US 5328484A · Somers et al. · 1994 [cited by applicant]
US 5396051A · Kuhn et al. · 1995 [cited by applicant]
US 5478316A · Bitdinger et al. · 1995 [cited by applicant]
US 5505324A · Danico · 1996 [cited by applicant]
US 5505706A · Maus et al. · 1996 [cited by applicant]
US 5536917A · Suppelsa et al. · 1996 [cited by applicant]
US 5622274A · Bright · 1997 [cited by applicant]
US 5738658A · Maus et al. · 1998 [cited by applicant]
US 5984899A · D'Alessio et al. · 1999 [cited by applicant]
US 6080461A · Wozniak et al. · 2000 [cited by applicant]
US 6394985B1 · Lin · 2002 [cited by applicant]
US 7762981B2 · Dacquay et al. · 2010 [cited by applicant]
US 7887506B1 · Smolyarov et al. · 2011 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 8133198B2 · Neer · 2012 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8734394B2 · Adams et al. · 2014 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9474780B2 · Bokvist et al. · 2016 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 11298462B2 · Atterbury et al. · 2022 [cited by applicant]
US 11331432B2 · Holmqvist et al. · 2022 [cited by applicant]
US 11357820B2 · Corvari et al. · 2022 [cited by applicant]
US 11369751B2 · Ruan et al. · 2022 [cited by applicant]
US 11452821B2 · LaFever et al. · 2022 [cited by applicant]
US 20020055712A1 · Neracher · 2002 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20050273061A1 · Hommann et al. · 2005 [cited by applicant]
US 20060224124A1 · Scherer · 2006 [cited by applicant]
US 20070270777A1 · Dacquay et al. · 2007 [cited by applicant]
US 20080097311A1 · Dacquay et al. · 2008 [cited by applicant]
US 20080097390A1 · Dacquay et al. · 2008 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20090036868A1 · Pinedjian et al. · 2009 [cited by applicant]
US 20090281496A1 · Matusch · 2009 [cited by applicant]
US 20100049125A1 · James et al. · 2010 [cited by applicant]
US 20100211005A1 · Edwards et al. · 2010 [cited by applicant]
US 20110034878A1 · Radmer et al. · 2011 [cited by applicant]
US 20110054414A1 · Shang et al. · 2011 [cited by applicant]
US 20110144594A1 · Sund et al. · 2011 [cited by applicant]
US 20110202011A1 · Wozencroft · 2011 [cited by applicant]
US 20110319813A1 · Kamen et al. · 2011 [cited by applicant]
US 20110319864A1 · Beller et al. · 2011 [cited by applicant]
US 20130237921A1 · Lannan et al. · 2013 [cited by applicant]
US 20130267897A1 · Kemp et al. · 2013 [cited by applicant]
US 20140236076A1 · Marshall et al. · 2014 [cited by applicant]
US 20140249483A1 · Kiilerich et al. · 2014 [cited by applicant]
US 20140263156A1 · Newsom et al. · 2014 [cited by applicant]
US 20140276637A1 · Massey, Jr. · 2014 [cited by applicant]
US 20150174325A1 · Young et al. · 2015 [cited by applicant]
US 20150246180A1 · Fenlon et al. · 2015 [cited by applicant]
US 20150246181A1 · Fourt · 2015 [cited by examiner]
US 20150273162A1 · Holmqvist · 2015 [cited by applicant]
US 20160001015A1 · Kucuk et al. · 2016 [cited by applicant]
US 20160354555A1 · Gibson et al. · 2016 [cited by applicant]
US 20160367763A1 · Tschirren et al. · 2016 [cited by applicant]
US 20170173264A1 · Bendek et al. · 2017 [cited by applicant]
US 20170215699A1 · Ouyang et al. · 2017 [cited by applicant]
US 20170216526A1 · Brereton et al. · 2017 [cited by applicant]
US 20170224929A1 · Sampson et al. · 2017 [cited by applicant]
US 20170246403A1 · Cowe et al. · 2017 [cited by applicant]
US 20170354790A1 · Atterbury et al. · 2017 [cited by applicant]
US 20170361034A1 · Scheller et al. · 2017 [cited by applicant]
US 20180250471A1 · Grimoldby · 2018 [cited by examiner]
US 20180339114A1 · Wendland et al. · 2018 [cited by applicant]
US 20190030249A1 · Gonzalez et al. · 2019 [cited by applicant]
US 20190192785A1 · Wendland et al. · 2019 [cited by applicant]
US 20190366000A1 · Cowe et al. · 2019 [cited by applicant]
US 20200114041A1 · Alas et al. · 2020 [cited by applicant]
US 20200121853A1 · Dobson et al. · 2020 [cited by applicant]
US 20200139046A1 · Jacobsen · 2020 [cited by examiner]
US 20200282144A1 · Pearson · 2020 [cited by applicant]
US 20200316314A1 · Buri et al. · 2020 [cited by applicant]
US 20210077732A1 · Egelhofer · 2021 [cited by applicant]
US 20210196900A1 · Apply et al. · 2021 [cited by applicant]
US 20220015429A1 · Brown et al. · 2022 [cited by applicant]
US 20220176042A1 · Belisle · 2022 [cited by applicant]
US 20220395640A1 · Schwartzentruber · 2022 [cited by applicant]
US 20230001099A1 · Dunn · 2023 [cited by applicant]
US 20230238105A1 · Schneider et al. · 2023 [cited by applicant]
US 20230347074A1 · Gavin · 2023 [cited by applicant]
US 20240009397A1 · In et al. · 2024 [cited by applicant]
US 20240065940A1 · Foucher et al. · 2024 [cited by applicant]
DE 2626811A1 · 1976 [cited by applicant]
DE 3921747A1 · 1991 [cited by applicant]
EP 3501577A1 · 2019 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2004058820A2 · 2004 [cited by applicant]
WO WO2004068820A2 · 2004 [cited by applicant]
WO WO2005018629A1 · 2005 [cited by applicant]
WO WO2006003388A2 · 2006 [cited by applicant]
WO WO2006030220A1 · 2006 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2015001819A1 · 2015 [cited by applicant]
WO WO2016081238A1 · 2016 [cited by applicant]
WO WO2018142167A1 · 2018 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
Hamers-Casterman et al., “Naturally occurring antibodies devoid of light chains,” Nature, Jun. 3, 1993, 363(6428):446-448. [cited by applicant]
Holt et al., “Domain antibodies: proteins for therapy,” Trends in Biotechnology, Nov. 2003, 21(11):484-490. [cited by applicant]
Muyldermans, “Single domain camel antibodies: current status,” Reviews in Molecular Biotechnology, Jun. 2001, 74(4):277-302. [cited by applicant]
Needle-based injection systems for medical use requirements and test methods, Part 1: Needle injection systems, ISO 11608 1:2014(E), Third Edition, Switzerland, ISO, Dec. 15, 2014, pp. 1-13. [cited by applicant]
Ward et al., “Binding activities of a repertoire of single immunoglobulin variable domains secreted from [cited by applicant]
U.S. Appl. No. 19/063,738, filed Feb. 26, 2025, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 19/064,399, filed Feb. 26, 2025, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 19/064,354, filed Feb. 26, 2025, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 19/064,379, filed Feb. 26, 2025, Alexander Hee-Hanson. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2025/045033, mailed on Jan. 27, 2026, 10 pages. [cited by applicant]
U.S. Appl. No. 19/063,738, Alexander Hee-Hanson, filed Feb. 26, 2025. [cited by applicant]
U.S. Appl. No. 19/064,354, Alexander Hee-Hanson, filed Feb. 26, 2025. [cited by applicant]
U.S. Appl. No. 19/064,379, Alexander Hee-Hanson, filed Feb. 26, 2025. [cited by applicant]
U.S. Appl. No. 19/064,399, Alexander Hee-Hanson, filed Feb. 26, 2025. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US2025/044876, mailed on Dec. 22, 2025, 20 pages. [cited by applicant]